RTSL — Rapid Therapeutic Science Laboratories Balance Sheet

0.000.00%

Last trade - 00:00

HealthcareHighly SpeculativeMicro Cap

Annual balance sheet for Rapid Therapeutic Science Laboratories, fiscal year end - December 31st, USD millions except per share, conversion factor applied.

	2019 March 31st	2020 March 31st	2020 December 31st	2021 December 31st	2022 December 31st
Period Length:	12 M	12 M	9 M	12 M	12 M
Source:	10-K	10-K	10-KT	10-K	10-K
Standards:	USG	USG	USG	USG	USG
Status:	Final	Final	Final	Final	Final
Cash
Cash and Short Term Investments	0.001	0.136	0.499	0.192	0
Total Inventory
Prepaid Expenses
Total Current Assets	0.001	0.142	0.686	0.419	0.233
Gross Property, Plant And Equipment
Accumulated Depreciation
Net Property, Plant And Equipment	0	—	0.599	1.61	1.85
Net Intangible Assets
Other Long Term Assets
Total Assets	0.001	0.445	1.51	2.2	2.25
Accounts Payable
Payable / Accrued
Accrued Expenses
Notes Payable / Short Term Debt
Current Portion of Long Term Debt / Capital Leases
Total Other Current Liabilities
Total Current Liabilities	0.97	1.49	1.21	3.05	4.97
Long Term Debt
Total Long Term Debt
Total Debt
Total Other Liabilities
Total Liabilities	3.17	1.81	1.52	3.58	5.4
Non Redeemable Preferred Stock
Common Stock
Additional Paid In Capital
Retained Earnings (Accumulated Deficit)
Treasury Stock
Total Equity	-3.17	-1.36	-0.011	-1.38	-3.14
Total Liabilities & Shareholders' Equity	0.001	0.445	1.51	2.2	2.25
Total Common Shares Outstanding